Kenneth E. Thorpe, PhD

For some seniors living with chronic diseases, one particular reform may actually lead to higher out-of-pocket costs

The Biden administration recently warned that Medicare could spend $3.5 billion on a new category of Alzheimer's drugs in 2025 alone – a figure vastly higher than what experts in the field predict – leading many to question the math.

New anti-obesity drugs are a new tool in fight against overweight, but more accessibility is needed.